Ahead of regulatory approval that is expected before the end of the year, Trinity Biotech chose Medica to present the novel point-of-care (POC) analyzer Meritas with the Troponin I (TnI) that are expected to disrupt a €700 million market.
“Our company has developed its own core technology for its colour Doppler ultrasound series”, proudly explained Alpha Zan, General Manager, Emperor Medical.
Ageing populations, struggling healthcare systems, medical staff shortages, rising costs – all are well recognised. Thus telemedicine, dubbed the ‘gold rush of the 21st century’ earlier in the year by Jonathan D Linkous, CEO of the American Telemedicine Association (ATA), is gaining momentum.
New technological opportunities make it continuously easier to use medical devices anywhere, for in- and out-patient care. The technology has become mobile – and so have the patients. In-patient monitoring can be carried out wirelessly, independent of a patient’s respective location.
Unisyn, a division of GE Healthcare that provides a multi-brand ultrasound probe repair solutions to biomedical and clinical engineers, is expanding product sales and services into Europe.
The Task Force Health Care (TFHC) was initiated in 1996 by the private sector; the Dutch government acts as a partner.
Although traditionally exporting timber and machinery, today Finland has established itself as a producer of high-tech products. This includes innovative medical technology.
Over the past decade, laboratory medicine developed rapid, accurate tests that help in diagnoses, prognoses, treatments – and the overall theragnostics; but is it economical? This November, at the Journées Internationales de Biologie (JIB) meeting in Paris, that question will shape the medical economics session Medical biology: a key factor in the healthcare effectiveness, organised by the in…
Frost & Sullivan is carefully tracking the transforming global point-of-care testing (POCT) market, offering latest information on key opportunities and critical unmet needs by region
908 Devices has good reason to be based in Boston’s Innovation District. A start-up founded in 2012, the company plans to disrupt the field of chemical analysis with what Vice President Chris Petty calls ‘ridiculously small, and elegantly simple’ mass spectrometry technology.
From the meetings between the Presidents of China and the USA came the slogan, ‘A new model of cooperation’. One item discussed was the proposed $4.6 billion purchase of a US pork producer by a Chinese company, which affirmed: ‘the acquisition won’t affect the quality of the bacon on stateside breakfast tables’.
CMEF, the China International Medical Equipment Fair, is a semi-annual tradeshow which presents innovative products from and for China, and a cornucopia of educational congresses, workshops on financing, seminars on regulatory and policymaking issues as well as networking opportunities.
Improving access to care still is a key goal of the Chinese national government. Broadening insurance coverage and supplying diagnostic devices as well as IT-based communication tools, in particular to the needy rural care providers, are major elements of the campaign for modernization.
The German Cancer Research Center (DKFZ) and Bayer HealthCare (Bayer) will extend their successful strategic research alliance in search of novel cancer therapeutics by focusing their activities also on the field of immunotherapy.
Vendors exhibiting strong leadership and understanding of interoperability standards to make gains
The 2013 turnover expected by German in vitro diagnostics producers are significantly lower compared to last year, according to a survey of members carried out by the German Diagnostics Industry Association (VDGH) presented in January at the Diagnostica Forum in Berlin.
New business ventures, new systems – and those include 3-D mammography
Late last year, at the German Hospital Procurement Congress in Berlin, we met with Durral R Gilbert, President of the US firm Premier Supply Chain Services, who was presenting cost-cutting strategies that reach far beyond reducing consumables and equipment prices – strategies that might also help hospitals in Europe.
Current trends in the medical tourism industry indicate that the needs of international patients are challenging health service providers to come up with advanced solutions for quality healthcare outcomes.
Over 32% of HIV+ people in Europe remain undiagnosed. This large untapped pool and the development of novel nucleic acid test (NAT) and non-NAT technology based platforms offers growth potential for HIV diagnostics manufacturers.
Founded in 1991 in Shenzhen, China, Mindray is now known internationally for its products that cover patient monitoring and life support, in-vitro diagnostics, medical imaging and veterinary. During Daniela Zimmermann’s interview with David Yin, General Manager of Mindray Europe, he described the firm’s clear strategy for Europe and beyond
The Medical Imaging & Technology Alliance (MITA) and the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry (COCIR) applauded President Barack Obama for initiating discussions around a Transatlantic Trade and Investment Partnership with the European Union.
A high unemployment rate coupled with an influx of refugees from Iraq and Syria has compounded challenges faced by the Jordanian government to provide healthcare for all, states a new report by healthcare experts GlobalData.
In 1963 Greiner Bio-One came into being with the opening of the Greiner Labortechnik production centre for laboratory products in Nürtingen, Germany.
The investment company Aurelius Group, based in Munich/Germany, has closed a deal to acquire Tieto’s divisions Healthcare, Systems Integration & Consulting, and Product Engineering Solutions as well as related activities in the Netherlands, Poland, and India.